4,598 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Jacobsen Capital Management

Jacobsen Capital Management bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 4,598 shares of the medical research company’s stock, valued at approximately $1,350,000. Thermo Fisher Scientific accounts for about 1.3% of Jacobsen Capital Management’s portfolio, making the stock its 17th largest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Employers Holdings Inc. acquired a new stake in Thermo Fisher Scientific in the second quarter valued at $441,000. Landmark Bank lifted its stake in Thermo Fisher Scientific by 0.6% in the second quarter. Landmark Bank now owns 13,583 shares of the medical research company’s stock valued at $3,989,000 after acquiring an additional 77 shares during the last quarter. Capital Wealth Planning LLC acquired a new stake in Thermo Fisher Scientific in the second quarter valued at $1,187,000. Comerica Bank lifted its stake in Thermo Fisher Scientific by 1.2% in the second quarter. Comerica Bank now owns 119,587 shares of the medical research company’s stock valued at $34,321,000 after acquiring an additional 1,381 shares during the last quarter. Finally, Next Capital Management LLC lifted its stake in Thermo Fisher Scientific by 232.7% in the second quarter. Next Capital Management LLC now owns 173 shares of the medical research company’s stock valued at $51,000 after acquiring an additional 121 shares during the last quarter. Institutional investors and hedge funds own 88.21% of the company’s stock.

Shares of NYSE TMO traded up $2.80 during mid-day trading on Friday, reaching $276.11. 22,773 shares of the company were exchanged, compared to its average volume of 1,590,454. The company’s 50-day simple moving average is $287.33 and its 200-day simple moving average is $272.12. The company has a quick ratio of 1.07, a current ratio of 1.49 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $109.46 billion, a P/E ratio of 24.86, a P/E/G ratio of 1.80 and a beta of 1.11. Thermo Fisher Scientific Inc. has a twelve month low of $208.34 and a twelve month high of $305.45.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.01 by $0.03. The company had revenue of $6.32 billion during the quarter, compared to analysts’ expectations of $6.31 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. Thermo Fisher Scientific’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the company posted $2.75 EPS. As a group, equities research analysts expect that Thermo Fisher Scientific Inc. will post 12.24 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, September 17th will be paid a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio is presently 6.83%.

A number of brokerages have commented on TMO. Wolfe Research began coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 30th. They issued an “outperform” rating for the company. Argus increased their price target on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Credit Suisse Group reiterated a “buy” rating and issued a $310.00 price target on shares of Thermo Fisher Scientific in a research note on Wednesday, July 31st. BTIG Research increased their price target on shares of Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a research note on Thursday, May 23rd. Finally, Needham & Company LLC increased their price target on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research note on Thursday, July 25th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $303.17.

In other news, CFO Stephen Williamson sold 2,500 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the completion of the sale, the chief financial officer now owns 40,029 shares in the company, valued at approximately $10,739,380.41. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the sale, the chief executive officer now owns 342,193 shares of the company’s stock, valued at approximately $97,466,832.19. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,775 shares of company stock valued at $14,986,676. 0.45% of the stock is currently owned by corporate insiders.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: Outstanding Shares

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.